Key result
Early coronary revascularization within 24 hours did not significantly reduce one-year all-cause mortality compared to delayed revascularization in patients with post-infectious non-ST elevation myocardial infarction (HR 0.935, p=0.742).
Why the study?
Coronary revascularization provides benefit in acute infection-associated AMI, but the optimal timing remains uncertain.
Does early coronary revascularization (within 24 hours) improve 30-day and one-year all-cause mortality compared to delayed revascularization in patients with post-infectious non-ST elevation myocardial infarction?
Cohort (n=239)
No
Does early coronary revascularization (within 24 hours) improve 30-day and one-year all-cause mortality compared to delayed revascularization in patients with post-infectious non-ST elevation myocardial infarction?
Hazard Ratio: 0.935 (95% CI 0.626–1.397)
Absolute Event Rate: 43% vs 40%
p-value: p=0.742
In patients with post-infectious non-ST elevation myocardial infarction, early coronary revascularization within 24 hours did not significantly improve 30-day or one-year all-cause mortality compared to delayed revascularization.
Should not yet change practice for early revascularization in post-infectious NSTEMI; leaves open optimal timing pending prospective trials.
OBJECTIVES: Acute infection is a well-known provocative factor of acute myocardial infarction (AMI). Prognosis is worse when it is associated with sepsis. Coronary revascularization is reported to provide benefit in these patients; however, the optimal timing remains uncertain. METHODS: This retrospective study was performed at a tertiary center in Taipei from January 2010 to December 2017. 1931 patients received coronary revascularization indicated for AMI. Among these, 239 patients were hospitalized for acute infection but later developed AMI. Patients with either an ST-elevation myocardial infarct or the absence of obstructive coronary artery disease were excluded. Revascularization was performed via either percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG). We defined early and delayed revascularization groups if it was performed within or after 24 hours of the diagnosis of AMI, respectively. We evaluated whether the timing of revascularization altered 30-day and one-year all-cause mortality. RESULTS: At one month, 24 (26%) patients died in early revascularization group and 32 (22%) patients in delayed revascularization group. At one year, 40 (43%) and 59 (40%) patients died on early and delayed revascularization groups respectively. Early revascularization did not result in lower 30-day all-cause mortality (P = 0.424), and one-year all-cause mortality (Hazard ratio (HR): 0.935; 95% confidence interval (CI): 0.626-1.397, P = 0.742) than delay revascularization. CONCLUSIONS: Timing of coronary revascularization of post infectious acute coronary syndrome may be arranged according to individual risk category as those without sepsis.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2022) conducted a cohort in Post-infectious non-ST elevation myocardial infarction (n=239). Early coronary revascularization vs. Delayed coronary revascularization was evaluated on One-year all-cause mortality (HR 0.935, 95% CI 0.626-1.397, p=0.742). Early coronary revascularization within 24 hours did not significantly reduce one-year all-cause mortality compared to delayed revascularization in patients with post-infectious non-ST elevation myocardial infarction (HR 0.935, p=0.742).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: